Cargando…

Reassessing carrier status for dystrophinopathies

Detalles Bibliográficos
Autores principales:	Newcomb, Tara M., Flanigan, Kevin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053119/ https://www.ncbi.nlm.nih.gov/pubmed/27761523 http://dx.doi.org/10.1212/NXG.0000000000000108

Ejemplares similares

Clinical and genetic characteristics of female dystrophinopathy carriers
por: Zhong, Jingzi, et al.
Publicado: (2019)

Medical Attitudes Survey for Female Dystrophinopathy Carriers in Japan
por: Kobayashi, Michio, et al.
Publicado: (2018)

Molecular Diagnosis in 100% of Dystrophinopathies: Are We There Yet?
por: Pegoraro, Elena
Publicado: (2021)

The Expanding Spectrum of Dystrophinopathies: HyperCKemia to Manifest Female Carriers
por: Suthar, Renu, et al.
Publicado: (2021)

Proof of Concept of the Ability of the Kinect to Quantify Upper Extremity Function in Dystrophinopathy
por: Lowes, Linda P, et al.
Publicado: (2013)

Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy
por: Juan-Mateu, Jonàs, et al.
Publicado: (2012)

Ataluren treatment of patients with nonsense mutation dystrophinopathy
por: Bushby, Katharine, et al.
Publicado: (2014)

A manifesting female carrier of Duchenne muscular dystrophy: importance of genetics for the dystrophinopathies
por: Quak, Zhi Xuan, et al.
Publicado: (2023)

Late-Onset Dystrophinopathy
por: Singh, Ranjan K
Publicado: (2021)

MicroRNAs in Dystrophinopathy
por: Lee, Ahyoung, et al.
Publicado: (2022)

Involvement of adiponectin in the pathogenesis of dystrophinopathy
por: Abou-Samra, Michel, et al.
Publicado: (2015)

Advances in Dystrophinopathy Diagnosis and Therapy
por: Saad, Fawzy A., et al.
Publicado: (2023)

Efficacy and safety of hydrokinesitherapy in patients with dystrophinopathy
por: Suslov, V. M., et al.
Publicado: (2023)

Clinical and Genetic Characterization of Female Dystrophinopathy
por: Lee, Seung Ha, et al.
Publicado: (2015)

Comprehensive genetic characteristics of dystrophinopathies in China
por: Ma, Peipei, et al.
Publicado: (2018)

Reassessing blood acetylcholinesterase in dementia
por: Han, Pengcheng
Publicado: (2015)

Comprehensive analysis for genetic diagnosis of Dystrophinopathies in Japan
por: Okubo, Mariko, et al.
Publicado: (2017)

Correction to: Comprehensive genetic characteristics of dystrophinopathies in China
por: Ma, Peipei, et al.
Publicado: (2021)

Needs management in families affected by childhood-onset dystrophinopathies
por: Conway, Kristin M, et al.
Publicado: (2019)

Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers
por: Hiermeier, Ursula M, et al.
Publicado: (2020)

Study of Dystrophinopathy in Eastern Uttar Pradesh Population of India
por: Kumari, Preeti, et al.
Publicado: (2018)

EMQN best practice guidelines for genetic testing in dystrophinopathies
por: Fratter, Carl, et al.
Publicado: (2020)

Long‐read whole‐genome sequencing for the genetic diagnosis of dystrophinopathies
por: Xie, Zhiying, et al.
Publicado: (2020)

The COVID-19 Pandemic Presents an Opportunity to Reassess the Value of Polysomnography
por: Patel, Sanjay R., et al.
Publicado: (2020)

Reassessing Joint Use Agreements to Promote the Public’s Health
por: Hodge, James G.
Publicado: (2015)

Reassessing the risks and benefits of COVID-19 precautions in 2023
por: Ollila, Thomas A., et al.
Publicado: (2023)

Urine mRNA to identify a novel pseudoexon causing dystrophinopathy
por: Antoury, Layal, et al.
Publicado: (2019)

X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy
por: Nakamura, Akinori
Publicado: (2015)

Genotypes and Phenotypes of DMD Small Mutations in Chinese Patients With Dystrophinopathies
por: Wang, Liang, et al.
Publicado: (2019)

Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy
por: de Feraudy, Yvan, et al.
Publicado: (2020)

Proteomic profiling of the interface between the stomach wall and the pancreas in dystrophinopathy
por: Dowling, Paul, et al.
Publicado: (2021)

Combining Protein Expression and Molecular Data Improves Mutation Characterization of Dystrophinopathies
por: Gaina, Gisela, et al.
Publicado: (2021)

Wechsler Scale Intelligence Testing in Males with Dystrophinopathies: A Review and Meta-Analysis
por: Weerkamp, Pien M. M., et al.
Publicado: (2022)

Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies
por: Bello, Luca, et al.
Publicado: (2016)

Interplay between DMD Point Mutations and Splicing Signals in Dystrophinopathy Phenotypes
por: Juan-Mateu, Jonàs, et al.
Publicado: (2013)

Proteomic Profiling of the Dystrophin-Deficient mdx Phenocopy of Dystrophinopathy-Associated Cardiomyopathy
por: Holland, Ashling, et al.
Publicado: (2014)

Dystrophinopathy Phenotypes and Modifying Factors in DMD Exon 45–55 Deletion
por: Poyatos‐García, Javier, et al.
Publicado: (2022)

Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations
por: Bourke, John, et al.
Publicado: (2022)

Reassessing the role of the neutrophil-to-lymphocyte ratio in chronic kidney disease patients
por: Lee, Yu Ho
Publicado: (2023)

Reassessing the Reassessment of suPAR in Glomerular Disease
por: Meijers, Björn K. I., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_is7hclg6m8ohpth61jn22ps2dj